Compare PTLO & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTLO | PACB |
|---|---|---|
| Founded | 1963 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.0M | 486.1M |
| IPO Year | 2021 | 2010 |
| Metric | PTLO | PACB |
|---|---|---|
| Price | $5.51 | $1.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $8.06 | $2.08 |
| AVG Volume (30 Days) | 1.5M | ★ 6.6M |
| Earning Date | 05-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $732,066,000.00 | $93,468,000.00 |
| Revenue This Year | $9.71 | $12.46 |
| Revenue Next Year | $6.20 | $12.10 |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | 3.03 | ★ 3.04 |
| 52 Week Low | $4.41 | $0.85 |
| 52 Week High | $14.47 | $2.73 |
| Indicator | PTLO | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 45.44 |
| Support Level | $5.34 | $1.68 |
| Resistance Level | $6.12 | $2.00 |
| Average True Range (ATR) | 0.33 | 0.14 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 36.27 | 52.04 |
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.